Thank you to the attendees, faculty, sponsors, and supporters of the Psychopharmacology Update for making the conference a tremendous success!  We hope to see you again in 2020. SIGN UP for email updates to keep informed of program developments for our upcoming conference as they become available.



Recent Breakthroughs in Psychopharmacology:
Novel Treatments

The 2019 Psychopharmacology Update is sold out.

Click here for more Psychiatry CME.

Message from the Director, Henry A. Nasrallah, MD

Dear Colleagues,

On behalf of the University of Cincinnati and CURRENT PSYCHIATRY, it is my pleasure to invite you to attend our 18th Annual Psychopharmacology Update.

At this full-day course, nationally renowned faculty will focus on Recent Breakthroughs in Psychopharmacology: Novel Treatments

Topics will include:

  • Long-Acting Injectables for Psychotic and Mood Disorders
  • Emergence of Hallucinogens as Novel Treatments for Depression, Anxiety and PTSD
  • Breakthrough Treatment for Postpartum Depression
  • Botulinum Toxic for Depression
  • Treatment for Clozapine-Resistant Psychosis
  • Treating Parkinson's Disease Psychosis with a Non-Dopaminergic Agent
  • Esketamine for Treatment-Resistant Depression

New for 2019 we are offering optional, pre-conference Addiction and Medical Cannabis Workshops on Friday, October 25.  Workshops have limited space available. First come. First served!

This well-established one-day CME symposium offers an outstanding opportunity for education and networking with minimal disruption to your busy schedule. You will get in-depth analysis from our expert faculty and ample time to query them on topics that will help keep your practice ahead of the curve.

I look forward to hosting this symposium in Cincinnati at the Kingsgate Conference Center (across the street from UC Medical Center).  I look forward to seeing past participants again, and many new faces as well!


Henry A. Nasrallah, MD 
Vice-Chair for Faculty Development and Mentorship
Professor of Psychiatry, Neurology, & Neuroscience
Director, Neuropsychiatry and Schizophrenia Programs
University of Cincinnati College of Medicine
Cincinnati, Ohio




Follow Us

Jointly Provided By